
### [MONDO:0000490](http://purl.obolibrary.org/obo/MONDO_0000490)
**Label:** glomerulosclerosis

**Subclasses:** [MONDO:0014451](http://purl.obolibrary.org/obo/MONDO_0014451) (focal segmental glomerulosclerosis 7), [MONDO:0014462](http://purl.obolibrary.org/obo/MONDO_0014462) (focal segmental glomerulosclerosis 8), [MONDO:0011917](http://purl.obolibrary.org/obo/MONDO_0011917) (focal segmental glomerulosclerosis 3, susceptibility to), [MONDO:0012931](http://purl.obolibrary.org/obo/MONDO_0012931) (focal segmental glomerulosclerosis 4, susceptibility to), [MONDO:0013191](http://purl.obolibrary.org/obo/MONDO_0013191) (focal segmental glomerulosclerosis 5), [MONDO:0011303](http://purl.obolibrary.org/obo/MONDO_0011303) (focal segmental glomerulosclerosis 1), [MONDO:0014539](http://purl.obolibrary.org/obo/MONDO_0014539) (focal segmental glomerulosclerosis 9), [MONDO:0011390](http://purl.obolibrary.org/obo/MONDO_0011390) (focal segmental glomerulosclerosis 2), [MONDO:0013589](http://purl.obolibrary.org/obo/MONDO_0013589) (focal segmental glomerulosclerosis 6), 

**Corr. equiv. classes:** [OMIM:603278](http://purl.obolibrary.org/obo/OMIM_603278), [OMIM:612551](http://purl.obolibrary.org/obo/OMIM_612551), [OMIM:603965](http://purl.obolibrary.org/obo/OMIM_603965), [OMIM:607832](http://purl.obolibrary.org/obo/OMIM_607832), [OMIM:613237](http://purl.obolibrary.org/obo/OMIM_613237), [OMIM:616002](http://purl.obolibrary.org/obo/OMIM_616002), [OMIM:614131](http://purl.obolibrary.org/obo/OMIM_614131), [Orphanet:93213](http://www.orpha.net/ORDO/Orphanet_93213), [OMIM:616220](http://purl.obolibrary.org/obo/OMIM_616220), [OMIM:616032](http://purl.obolibrary.org/obo/OMIM_616032), 

**Class expressions from DL-Learner:**

- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 74.30%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) 67.74%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0011277](http://purl.obolibrary.org/obo/HP_0011277) (Abnormality of the urinary system physiology) 67.74%
- [HP:0000096](http://purl.obolibrary.org/obo/HP_0000096) (Glomerulosclerosis) 63.90%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0012622](http://purl.obolibrary.org/obo/HP_0012622) (Chronic kidney disease) 62.73%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0003110](http://purl.obolibrary.org/obo/HP_0003110) (Abnormality of urine homeostasis) and [HP:0012622](http://purl.obolibrary.org/obo/HP_0012622) (Chronic kidney disease) 62.27%
- [HP:0000093](http://purl.obolibrary.org/obo/HP_0000093) (Proteinuria) and [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0012622](http://purl.obolibrary.org/obo/HP_0012622) (Chronic kidney disease) 62.27%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0000100](http://purl.obolibrary.org/obo/HP_0000100) (Nephrotic syndrome) 60.62%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0012622](http://purl.obolibrary.org/obo/HP_0012622) (Chronic kidney disease) 58.71%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0000100](http://purl.obolibrary.org/obo/HP_0000100) (Nephrotic syndrome) and [HP:0012622](http://purl.obolibrary.org/obo/HP_0012622) (Chronic kidney disease) 55.36%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0003774](http://purl.obolibrary.org/obo/HP_0003774) (Stage 5 chronic kidney disease) 53.33%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0003110](http://purl.obolibrary.org/obo/HP_0003110) (Abnormality of urine homeostasis) and [HP:0003774](http://purl.obolibrary.org/obo/HP_0003774) (Stage 5 chronic kidney disease) 50.36%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003774](http://purl.obolibrary.org/obo/HP_0003774) (Stage 5 chronic kidney disease) 50.36%
- [HP:0000093](http://purl.obolibrary.org/obo/HP_0000093) (Proteinuria) and [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0003774](http://purl.obolibrary.org/obo/HP_0003774) (Stage 5 chronic kidney disease) 50.36%
- [HP:0012211](http://purl.obolibrary.org/obo/HP_0012211) (Abnormal renal physiology) 46.21%


